APA

Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.

An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.

Experts discuss appropriate interventions for patients who are victims of undue influence at the 2022 APA Annual Meeting.

Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.

The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.

Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.

Our Editor in Chief is thrilled to be live and in person at the 2022 APA Annual Meeting in New Orleans. Here's why.

"When we embrace humanity, everyone wins."

How do social stressors contribute to patient symptoms?

What are the neuropsychiatric effects of sparring in mixed martial arts? New research presented at the 2022 APA Annual Meeting elucidates the issues.

What are the Psychiatric Times™ Editorial Board Members talking about at the 2022 APA Annual Meeting in New Orleans?

Research explored how a traumatic explosion affected individuals around the world.

What are the current dosing guidelines for the implementation of pharmacogenetics into practice?

How can we more effectively help patients with PTSD? Charles B. Nemeroff discusses the diagnosis, epidemiology, and pathophysiology of PTSD, along with current and emerging treatments, at the 2022 APA Annual Meeting.

How can we help individuals who are under undue influence or authoritative control?

Do classification systems make a difference? A presentation at the 2022 APA Annual Meeting noted 4 key diagnoses that differ significantly in the classification systems.

New research presented at the 2022 American Psychiatric Association Annual Meeting evaluated program to help address the opioid epidemic.

A look at the theme for the 2022 American Psychiatric Association Annual Meeting.

The Accelerating Medicines Partnership in Schizophrenia aims to develop better treatments for the early stages of psychotic illness.

This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.

What is the clinical impact of climate psychiatry?

Christine Yu Moutier, MD, is excited to see you at the APA Annual Meeting in New Orleans!

If you're attending APA 2022 in New Orleans, here are some other things to check out in the city.

Are you attending the APA Annual Meeting in New Orleans? Here's a preview of one doctor's talk on jazz and racism.

Are you attending APA’s 2022 Annual Meeting in New Orleans? Don’t miss us!

As the nation continues to grapple with the children’s mental health crisis, the American Psychiatric Association Council on Children, Adolescents, and Their Families is exploring the ways in which clinicians can best support their patients.

Sleep problems are understudied, underdiagnosed, and undertreated.

Joshua A. Gordon, MD, PhD, National Institute of Mental Health Director, leverages lessons from past natural disasters and traumas to foster resiliency and inform future research endeavors.

In his William C. Menninger Memorial Lecture, Anthony S. Fauci, MD, shared lessons learned and remaining challenges for the COVID-19 pandemic, especially in terms of mental health and behavioral issues.

What is excited delirium syndrome and how should it be treated? The short answer is we do not know.